Unfortunately, not all clinical trials give us positive results. The lampalizumab/”lamp stuff” for dry AMD that we’ve talked about before has failed phase 3. They’ll be looking at the data to see if there’s something they might have missed. As for the other proposed treatment for dry AMD, the Lumithera Photobiomodulation device, although it is listed on the US clinicaltrials.gov website, it’s listed as “not applicable.” That’s not necessarily bad news, it means that for those of with dry AMD, we are…
From 2017
Are you concerned that being visually impaired means you won’t be able to travel & take vacations? Sue’s found several articles with suggestions, including one where you can go…